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Abstract
Background: Presumably bundling/co-packaging of zinc with ORS encourages the combined use of the products
for diarrhea treatment; however, empirical evidences are scarce. The purpose of this work is to evaluate whether
co-packing using a plastic pouch can enhance the joint adherence to the treatment or not. The study also
compares the cost effectiveness (CE) of two co-packaging options: ‘central’ and ‘health center (HC)’ level bundling.
Methods: This cluster-randomised controlled trial was conducted in 2015 in eight districts of Ethiopia. Thirty two
HCs were randomly assigned to one of the following four intervention arms: (i) ‘Central bundling’ (zinc and ORS
bundled using a pouch that had instructional message, distributed to HCs); (ii) ‘HC level bundling’ (zinc, ORS and a
similar pouch distributed to the HCs and bundled by health workers); (iii) ‘Bundling without message’ (zinc, ORS
and plain pouch distributed and bundled by the health workers); and, (iv) ‘Status quo’ (zinc and ORS co-administered
without bundling). In each of the four arms, 176 children 6–59 months of age, presented with acute diarrhea were
enrolled. Twelve days after enrollment, level of adherence was assessed. A composite scale of adherence was
developed and modeled using mixed effects linear regression analysis. The unit costs associated with the arms were
estimated using secondary data sources. Incremental CE analysis was made by taking the cost and level of adherence
in fourth arm as a base value.
Results: The follow-up rate was 95.6 %. As compared with the ‘status quo’ arm, the joint adherences in the ‘central’
and ‘HC level’ bundling arms raised substantially by 14.8 and 15.7 percentage points (PP), respectively (P < 0.05). No
significant difference was observed between ‘bundling without message’ and the ‘status quo’ arms. The unit cost
incurred by the ‘central bundling’ is relatively higher (USD 0.658/episode) as compared with the ‘HC level bundling’
approach (USD 0.608/episode). The incremental CE ratio in the ‘central bundling’ modality was two times higher than
in the ‘HC based bundling’ approach.
Conclusion: Bundling zinc with ORS using a pouch with instructional messages increases adherence to the treatment.
‘HC level bundling’ is more CE than the ‘central bundling’ approach.
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Background
Diarrhea remains the second leading cause of death
among infants and young children, accounting for 18 %
of mortality and 13 % of all Disability-Adjusted Life
Years [1]. Among children younger than 5 years, each
year diarrhea kills around 760,000 children and causes
1.7 billion illnesses [2, 3]. Of all child deaths from diar-
rhea, 78 % occur in the Africa and South-East Asia [4].
Despite the recent decline in infant (50/1000 live
births (LB)) and under five (88/1000 LB) mortality rates,
in Ethiopia child morality still remains high [5]. In
the country 22 % of childhood deaths are attributable
to diarrhea [4]. Furthermore, according to Ethiopia
Demographic Health Survey (DHS) 2011, 13 % chil-
dren younger than 5 years had diarrhea in the pre-
ceding two weeks and the figure was as high as 25 %
amongst children 6–11 months of age [5].
Despite the alarming statistics, diarrhea is highly treat-
able. More than three-quarters of all diarrhea deaths
could be averted with full coverage and utilization of
Oral Rehydration Salt (ORS) and adjunct zinc supple-
mentation [6]. There is unequivocal evidence that thera-
peutic zinc supplementation decreases the duration and
severity of diarrheal episode and the likelihood of subse-
quent infections in the 2–3 months following treatment
[7–9]. Zinc supplementation also cut diarrhea related
mortality by nearly one quarter [10].
Its recommend that under-five years old children
should receive 10–14 days of zinc treatment for diarrhea
[11]. However, an increasing number of studies are
showing that adherence to zinc is unsatisfactory [12–16].
A study in Kenya reported that among mothers who re-
ceived diarrhea treatment for their children, 62 % re-
ported giving zinc for fewer than the recommended
10 days [12]. In Bangladesh two studies reported 56 %
[14] and 62 % [15] adherence to the full ten days treat-
ment course. In Mali, less than two-thirds (64 %) re-
ceived the entire 14-day treatment [13]. In India, at the
7th day of treatment, 82 % of children had already
stopped taking the supplement [16].
Bundling (co-packaging) of zinc with ORS may en-
courage their combined use, and enhance access to and
utilization of the treatment [17, 18]. On-pack informa-
tion can also serve as education and communication
tool. A study conducted in Western Guatemala found,
bundling of zinc with ORS in a graphic co-pack with in-
structions and provider messages for counseling signifi-
cantly improved both the prescription practices of
health professionals and adherence to zinc treatment of
mothers [19]. Formative research in Cambodia also
concluded that co-packaging is an effective means of
encouraging the combined use zinc and ORS [20].
The gray literature indicates many countries in the
developing world including Kenya, Uganda, Zambia,
Nigeria, Benin, Cambodia and Guatemala are initiating
co-packaging of zinc and ORS for diarrhea treatment.
Likewise, in Ethiopia, with the support of Micronutrient
Initiative (MI), the Pharmaceuticals Fund and Supply
Agency (PFSA) has launched the distribution of the bun-
dled products in selected regions of the country. Never-
theless, limited evidence exists regarding the effectiveness
of the intervention.
Bundling of zinc and ORS can be implemented in
two approaches. Readymade centrally bundled prod-
ucts can be distributed to the health institutions
(Central bundling) or the products can be dispatched and
health workers do the bundling at health institution level
(health center (HC) level bundling). Nevertheless, com-
parative cost effectiveness (CE) has not been made.
Thus, the purpose of this study is to evaluate whether
co-packing of zinc with ORS using a plastic pouch can
enhance the joint adherence to diarrhea treatment or
not. The study also compared the CE (cost per unit of a
defined health outcome [21]) of ‘central’ and ‘health
center (HC)’ level bundling approaches as a means to
provide empirical evidence for decision making.
Methods
Trial design
The study was a cluster-randomised controlled trial with
four parallel intervention arms and an allocation ratio
of 1.
Participants
The study was conducted in 32 HCs selected across 8
districts of Tigray, Amhara, Oromya and Southern
Nations, Nationalities and Peoples (SNNP) regions of
Ethiopia. In Ethiopia, HC is part of the primary health
care system that provides preventive and basic curative
services. The study districts were Laelay Maychew, Enda
Mehoni, Tehuledere, Dera, Dendi, Dodola, Misrak
Badwacho and Aleta Wondo.
Children 6–59 months of age presented with diarrhea in
the HCs during the study period (January to March, 2015)
where eligible for enrolment. Children presented with per-
sistent diarrhea (lasting for 14 days or more), bloody diar-
rhea or severe dehydration [22] were excluded. Likewise,
those who came outside the catchment area of the HCs or
from inaccessible localities weren’t included.
Intervention
Thirty two HCs were randomly allocated to one of the
following four parallel intervention arms:
1. Central bundling: Pre-bundled zinc and ORS using a
pouch that had instructional message intended for
improving the rational use of zinc-ORS treatment,
distributed to HCs (Fig. 1).
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2. HC level bundling: Zinc, ORS and bundling pouch
distributed to the HCs and bundling was made by the
health workers while administrating the treatment.
The pouch also carries similar instructional messages
as in the first arm.
3. Bundling without message: Zinc, ORS and plain
pouches without messages distributed to the HCs
and bundling was carried out by the health workers.
4. The status quo: Zinc and ORS co-administered
without bundling.
Enrollment of cases was made on an ongoing basis
while the caregivers visited the HCs for treatment.
During first contact, baseline data were collected,
treatment administered according to the study proto-
col and the address of the household was registered.
Two weeks later, respondents were visited at their
home and adherence was assessed based on the self
report of parents/caregivers. Data were collected by
96 trained health professionals working in the se-
lected HCs using a pretested questionnaire prepared
in the local languages.
Outcome of the study
The primary outcome of the study was level of joint ad-
herence to zinc and ORS treatment; secondary outcomes
were level of independent adherence to zinc and ORS
treatment.
Adherence to zinc was calculated as percentage of zinc
tablets given to the baby out of the ten provided at the
HC; whereas, adherence to ORS was computed as per-
centage of times ORS was administered after the child
had diarrheal episodes. Joint adherence to zinc and ORS
measured using a composite index developed by assign-
ing a weight of 0.5 to each of the zinc and ORS adher-
ence index.
Sample size
The sample size required for assessing the level of adher-
ence and cost-effectiveness (CE) was computed via the
GPower 3.15 software [23] using sample size calculation
formula for comparison of means. The inputs were; 95 %
confidence level, 90 % power, 0.3 effect size to be detected
as significant, an allocation ratio of 1, design effect of 1.7
(calculated based on the expected intra-cluster correlation
and cluster size [24, 25]) and 15 % compensation for loss
to follow-up. Ultimately the sample size was computed as
704 children, i.e. 176 per each arm.
Randomization
From each of the four regions (Tigray, Amhara, Oromya
and SNNP) two districts were selected at random. Then
Fig. 1 Design of the pouch used for bundling zinc with ORS
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from each district, 4 HCs having relatively high patient
flow were selected. Then four of the HCs selected from
each district were randomly allocated to the four arms
via the lottery method. Randomisation was done by one
of the principal investigators. Finally based on the eligi-
bility criteria, 22 subjects were recruited from each HC
using quota sampling technique.
Blinding
The study did not involve any kind of blinding as it was
not possible.
Statistical methods
The data were entered and analyzed using SPSS 19.0
and STATA SE 12 software. The analysis was made ac-
cording to the initial treatment arm assignment. Prior to
comparing the level of adherence in the four arms, the
socio-demographic profiles of the groups were com-
pared. Categorical variables were evaluated using chi-
square test; whereas numeric measures, depending on
their normality, assessed using ANOVA or kruskal
Wallis test.
The levels of adherence across the four intervention
arms were compared using mixed effects multiple lin-
ear regression model (with random intercepts for re-
gion, district and HC) adjusted for two variables that
showed significant variation across the arms. Prior to
analysis the assumptions of linear regression were
assessed.
Wealth index was computed using principal compo-
nent analysis as a composite indicator of living standard
based on ownership of selected household assets, size of
agricultural land, quantity of livestock, materials used
for housing construction, and ownership of improved
water and sanitation facilities. Ultimately wealth tertiles
were generated.
The unit costs associated with the three arms (exclud-
ing ‘bundling without message’ arm) were estimated
based on different secondary data sources. Various direct
costs (costs for purchasing zinc, ORS and bundling
pouch; cost for printing the messages on the pouch) and
indirect costs (costs of transportation for the aforemen-
tioned items, marginal manpower cost for conducting
the bundling at central and HC levels, and intellectual
cost for developing the message printed on the pouch)
were estimated. The costs are calculated as an aggregate
of all inputs which are identified, measured and there-
after valued at determined unit costs.
With the intension of making macro level comparisons,
the hypothetical total annual expenses of the country for
treating acute watery diarrhea using the three different ap-
proaches were estimated. The computation was made by
multiplying the unit cost for treatment by the ex-
pected number of health institution based diarrhea
treatments per annum. Information regarding the ap-
proaches used to estimate unit cost and total national
cost is provided as an auxiliary file (Additional file 1).
Incremental CE analysis was made by taking the added
Percentage Points (PP) of adherence for joint zinc-ORS
treatment as the sole measure of effectiveness. The cost
and level of adherence in the fourth arm (the usual way
of distribution without bundling) was taken as the base
value. CE ratio was calculated by dividing the added unit
costs with the added PP in adherence.
Results
Characteristics of the respondents and the study subjects
In the baseline study 704 children (176 from each arm)
were enrolled. In vast majority of the cases, data were
collected from the mothers of the index children. The
sex and age profiles of the children were not significantly
different (P > 0.05). However, with the average male to
female ratio of 1.22, more boys than girls were enrolled.
The variation in the mean (±SD) age of the respondents
was marginally insignificant (p = 0.063). Proportion who
fell in the poor household wealth tertile ranged from
30.1 % in the ‘status quo’ to 36.4 % in the ‘HC level
bundling’ group (p = 0.097). The distribution of socio-
demographic characteristics of the cases and respon-
dents during the baseline survey was not significantly
different (Table 1).
About 673 (95.6 %) of the cases were successfully
followed and household data were collected. The
remaining cases could not be traced during the house-
hold interviews. The follow-up rates ranged from 93.2 %
in the ‘HC level bundling’ to 98.3 % in ‘bundling without
message’ arms, but the figures were not significantly dif-
ferent (p = 0.123). The median duration between the
baseline and follow-up interviews was 12 days and varied
from 10 to 23 days (p = 0.163). The socio-demographic
characteristics of the subjects who completed the follow-
up were not statistically different (Fig. 2).
Severity and duration of the diarrheal illness
Severity of illness and other treatments provided might
independently affect the adherence to zinc-ORS treat-
ment. In overall, the arms were significantly different
based on the number of reported episodes of diarrhea in
the preceding day of the baseline survey (p < 0.001)
and the extent of dehydration during initial presenta-
tion (p = 0.004). Differences on the median duration
of illness at the time of the baseline study were mar-
ginally insignificant (p = 0.069). During enrollment,
children from the ‘HC level bundling’ arm appear to
have a longer and more frequent diarrheal episodes
and a higher proportion exhibited signs of dehydra-
tion (Table 2).
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Table 1 Characteristics of the respondents and the cases during the baseline survey in the four arms of the study, Jan-Mar 2015









Type of the respondent (%)
Mothers 92.0 89.8 92.0 92.0 0.832
Other primary caregiver 8.0 10.2 8.0 8.0
Mean age (± SD) of the respondents (years) 28.2 (±7.6) 26.9 (±6.3) 28.4 (±6.7) 26.8 (±6.9) 0.063
Mean parity (± SD) 3.4 (±2.1) 3.0 (±2.0) 3.4 (±2.1) 3.3 (±2.1) 0.266
Educational status (%)
No formal education 51.1 46.6 51.7 53.4 0.231
Primary education 27.8 27.3 21.6 29.5
Secondary education or above 21.0 26.1 26.7 17.0
Occupation (%)
Housewife/farmer 90.0 93.2 86.4 90.3 0.187
Others 9.1 6.8 13.6 9.7
Marital status (%)
Married/living together 92.6 92.6 96.0 95.5 0.364
Others 7.4 7.4 4.0 4.5
Household wealth index (%)
Poor 31.8 36.4 30.1 34.7 0.097
Middle 28.9 34.7 40.9 29.0
Rich 39.3 29.0 29.0 36.4
Age of the child (months) (%)
6–11 39.3 30.7 30.1 34.1 0.151
12–23 39.3 42.6 39.8 46.6
24–59 21.4 26.7 30.1 19.3
Sex of the child (%)
Boys 59.0 55.1 53.4 52.3 0.614
Girls 41.0 44.9 46.6 47.7
Fig. 2 Flow diagram of the study
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Despite the assumption that children with acute
watery diarrhea typically don’t need antibiotic and an-
tiparasitic medications, very significant proportion
(ranging from 35.9 to 44.4 %) received such treat-
ments. Nevertheless, the figures were not statistically
different across the arms (p = 0.257). The proportion
of caretakers who sought treatment elsewhere prior to
coming to the study HCs were not significantly differ-
ent (p = 0.247).
Adherence to zinc supplementation
The caretakers were asked to quantify how many of the
10 zinc tablets prescribed were actually given to the
child. In the ‘status quo’ arm only 37.9 % of the children
received the full ten days treatment course. The corre-
sponding figures for the ‘bundling without message’, ‘HC
level bundling’ and ‘central bundling’ were 45.7 %,
64.6 % and 65.9 %, respectively.
On average, across the four arms, the average (±SD)
number of tablets given was reported as 7.70 (±2.90).
Based on ANOVA, the adherence level was significantly
higher in the ‘HC level bundling’ (8.55 ± 2.31) and
‘central bundling’ (8.50 ± 2.56) groups; and lower in
‘bundling without message’ (7.23 ± 3.19) and ‘status quo’
(6.70 ± 3.36) arms (p < 0.001). No difference was ob-
served between the latter two arms (p = 0.557). Likewise,
the variation between the ‘central’ and ‘HC level’ bund-
ling groups was insignificant (p = 0.999) (Fig. 3).
The level of zinc adherence in the intervention arms
was also compared using a mixed effects multivariate
linear regression model in which adjustments were made
for two potential confounders (number of episodes of
diarrhea and extent of dehydration during the first pres-
entation). Compared with the ‘bundling without mes-
sage’ group, ‘central bundling’ and ‘HC level bundling’
significantly increased zinc adherence by 1.35 and 1.41
tablets (i.e. by 13.5 and 14.1 PP, respectively), respect-
ively. Likewise, compare with the ‘status quo’ group, the
two groups significantly increased adherence by 1.76 and
1.94 tablets (i.e. by 17.6 and 19.4 PP), respectively. No
difference was observed between the ‘status quo’ and
‘bundling without message’ arms (p = 0.319); and be-
tween ‘central bundling’ and ‘HC level bundling’ arms
(p = 0.894) (Table 3).
Adherence to ORS
According to the national guideline for the treatment of
acute watery diarrhea, children should receive ORS after
every diarrheal episode. About 63.9 % of the respondents
from the ‘status quo’ arm reported that they provided
ORS every time after an episode as recommended. The
corresponding figures for the ‘bundling without message’,
‘central bundling’ and ‘HC level bundling’ were 64.2, 79.0
and 80.5 %, respectively.
Overall, the average adherence levels for ORS treat-
ment in the four arms (i.e. proportion of diarrheal epi-
sodes followed by ORS administration) were: ‘HC level
bundling’ (87.8 %), ‘central bundling’ (87.5 %), ‘status
quo’ (76.1 %) and ‘bundling without message’ (76.0 %).
Table 2 Severity and duration of diarrhea among study children across the four intervention arms during the baseline survey,
Jan-Mar 2015








message (n = 173)
Median duration of illness during the baseline study (days) 3 3 2 2 0.069
Mean (±SD) number of episodes in the preceding day of survey 5.3 (±1.4) 6.2 (±2.5) 6.0 (±2.5) 5.5 (±2.0) <0.001*
Extent of dehydration (%)
No dehydration 74.9 65.2 76.9 82.1 0.004*
Some dehydration 25.1 34.8 23.1 17.9
% who sought for treatment elsewhere before coming to HC 4.8 9.1 4.7 8.1 0.247
% who received antibiotic or antiparasitic drugs at the HC 35.9 39.0 44.4 39.3 0.461
* Statistically significant difference at p value of 0.05
Fig. 3 Independent and joint adherence to zinc and ORS across the
four intervention arms of the study, Jan-Mar 2015
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In the mixed effects multivariate linear regression
model adjusted for the two potential confounders, no
significant difference was observed on the level of ORS
adherence between ‘central’ and ‘HC level’ bundling
(p = 0.969) and ‘bundling without message’ and ‘status
quo’ interventions groups (p = 0.966). However, as
compared with the other two groups, the ‘central’ and
HC level’ bundling interventions increased ORS ad-
herence by 10.2 to 12.0 PP (P < 0.05).
Adherence to joint zinc-ORS treatment
The intent of co-packing is to enhance the combined
use zinc and ORS for diarrhea treatment and to avoid
the use of zinc as a replacement therapy for ORS. Hence
assessing the joint adherence is imperative. The joint ad-
herence level in the ‘central’ (86.4 %) and ‘HC level’
bundling (86.5 %) arms was comparable and significantly
higher than the level in the other two arms. The joint
adherence in the ‘bundling without message’ (74.1 %) ap-
pears to be higher than the corresponding figure
(71.6 %) in the ‘status quo’ arm, but the difference was
not statistically significant.
In the mixed effects multivariate linear regression
model, similar pattern of association was witnessed. As
compared with the ‘status quo’ arm, the joint adherences
to zinc and ORS in ‘central’ and ‘HC level’ intervention
groups were significantly increased by 14.8 and 15.7 PP,
respectively. Likewise, taking the ‘bundling without mes-
sage’ as the reference group, the joint adherence level
was increased by 12.6 and 12.0 PP both in ‘central’ and
‘HC level’ arms.
Reasons for not adhering to zinc-ORS treatment
Among 300 caregivers who missed 2 or more zinc
tablets the underlying reasons were appraised. The
most frequently mentioned causes were; recovery of
the child (42.3 %), the child did not like it (25.3 %),
forgetfulness (21.7 %), and occurrence of perceived
side effects (13.0 %). Similarly among 190 respondents
who at least once failed to give ORS after a diarrheal
episode, the underlying reasons for not doing so were;
the child did not like it (52.6 %), thinking that ORS
does not help the child much (20.0 %), forgetfulness
(12.6 %), underestimating the seriousness of the dis-
ease (10.5 %) and giving preference to homemade
fluids (7.9 %).
Estimated unit and total national cost for diarrhea
treatment
The costs associated with the three strategies (central
bundling, HC level bundling and the status quo) were
estimated based on various assumptions. The unit cost
incurred by the ‘central bundling’ approach is relatively
higher (USD 0.658/episode) as compared with that of
‘HC level bundling’ approach (USD 0.608/episode). Ex-
pectedly, the ‘status quo’ modality is cheaper (USD
0.556/episode).
In terms of the total national cost, the ‘status quo’
approach requires the health sector to invest USD
6,283,474 for diarrhea treatment per annum, given all
the assumptions made for estimation are kept constant.
The ‘HC level bundling’ and the ‘central bundling’ re-
quire an additional USD 559,256 and 1,156,184 invest-
ments, respectively. Likewise, the ‘central bundling’ as
compared to the ‘HC level bundling’ approach requires
an additional USD 596,928 per annum.
Incremental CE of the central and HC level approaches
The incremental CE of the ‘central’ and ‘HC level’ bund-
ling approaches was computed by taking the ‘status-quo’
as the base level. CE ratio was calculated by dividing
added unit costs with the associated PP improvement in
joint zinc-ORS adherence. The ratios for the ‘central’
and ‘HC level’ bundling approaches were 0.007 and
0.003, respectively. These can be interpreted as, in central
and HC level bundling approaches, a PP improvement
Table 3 Pairwise comparison of the intervention arms using
mixed effects multivariate linear regression model based on
zinc, ORS and joint adherence, Jan-Mar 2015
Pairwise combination P value β coefficient a
Zinc adherence (%)
Central bundling vs HC level bundling 0.894 −0.4
Central bundling vs Bundling without message 0.001* 13.5
Central bundling vs Status quo <0.001* 17.6
HC level bundling vs Bundling without message 0.002* 14.1
HC level bundling vs Status quo <0.001* 19.4
Bundling without message vs Status quo 0.319 4.2
ORS adherence (%)
Central bundling vs HC level bundling 0.969 0.2
Central bundling vs Bundling without message 0.007* 11.5
Central bundling vs Status quo <0.001* 12.0
HC level bundling vs Bundling without message 0.022* 10.2
HC level bundling vs Status quo 0.003* 12.1
Bundling without message vs Status quo 0.966 −0.3
Joint zinc and ORS adherence (%)
Central bundling vs HC level bundling 0.965 −0.1
Central bundling vs Bundling without message 0.002* 12.6
Central bundling vs Status quo <0.001* 14.8
HC level bundling vs Bundling without message <0.001* 12.0
HC level bundling vs Status quo <0.001* 15.7
Bundling without message vs Status quo 0.673 1.8
* Statistically significant association at p value of 0.05
a Unstandardized multiple linear regression coefficient adjusted for number of
episodes of diarrhea and level of severity of dehydration
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in joint Zinc-ORS adherence can be achieved by
investing 0.7 and 0.3 cents/diarrhea episode, respect-
ively. The Cost-effectiveness ratio was two times
higher in the ‘central bundling’ modality as compared
with the counterpart. The evidence shows, ‘HC level
bundling’ is more cost-effective than ‘central bundling’
(Table 4).
Discussion
Co-packaging of zinc with ORS can enhance adherence
to treatment in a couple of ways. The bundling can cre-
ate a notion that zinc and ORS are parts of a protocol
and should not be used as stand-alone products; further,
on-pack instructions can serve as an information and
education tool. In the current study, the better adher-
ence observed in the ‘central’ and ‘HC level’ arms and
the absence of sizable difference between the other two
arms demonstrate that the benefit is predominantly due
to the effect of instructional messages provided on the
pouch.
The positive effect of bundling zinc with ORS using a
pouch with instructional messages has also been wit-
nessed elsewhere. A study in Guatemala reported that
provision of the products in a graphic co-pack with in-
structions significantly improved both the prescription
practices and adherence to zinc. Mothers who received
the co-pack had 1.7 times increased probability of pro-
viding the full 10 days of zinc treatment than their coun-
terparts [19]. Experiences of social marketing of zinc in
Cambodia also showed that co-packaging and an in-
structional insert had encouraged the combined use of
the products [20].
In this study the level of zinc, ORS and joint adher-
ences were comparable in the central and HC level
bundling arms. However, the CE was better in the latter.
Nevertheless, from program implementation point of
view, apart from CE, other feasibility parameters includ-
ing sustainability and acceptance of the task by health
workers and PFSA should be evaluated.
As the study followed an interventional design, the
reported level of adherence is unlikely to illustrate
the existing practice in the study districts. Neverthe-
less, the ‘status quo’ arm may provide surrogate infor-
mation. In this arm, merely 38 % of the respondents
adhered to the full ten days zinc treatment indicating
compliance is suboptimal. Increasing numbers of
studies are witnessing the same. For instance, the
complete adherence to the full 10 days zinc treatment
course was as low as 29 % in Madagascar [26], 38 %
in Kenya [12] and 44 % in Bangladesh [15]. Con-
versely, better level of adherence had been reported
in Mali [13] and Nigeria [27].
In the current study the most frequently forwarded
reason for discontinuation of zinc is recovery of the
child. The fact that diarrheal illness typically lasts for
few days but zinc is expected to be provided for 10–
14 days creates a challenge for adherence. Another
study based on a synthesis of formative research re-
sults from nine countries including Ethiopia also con-
cluded that, the major barriers to the full course of
zinc include the common practice of stopping treat-
ment when diarrhea stops and a lack of caregiver
awareness of the benefits of zinc for prevention of
diarrhea [28]. It is therefore important to include in
promotional material, strong communication on the
need to complete the dosage regardless of whether
the child’s diarrhea has ceased.
The findings of the study should be interpreted in con-
sideration of its limitations. Adherence was assessed
based on the caregivers’ report. Consequently, the
level is likely to be overestimated due to social desir-
ability bias. Further, adherence to ORS was assessed
based on the proportion of diarrhea episodes that
were followed by ORS administration. Remembering
the total number of diarrheal episodes is evidently
challenging and its liable recall errors. The data were
only collected from HCs hence the findings may not
be inferred to other types of health institutions as the
type of health provider and clients’ characteristics
may vary.
Regarding the CE analysis, the following limitations
should be noted. The analysis is made by taking the
number of added units of zinc-ORS adherence as the
sole measure of effectiveness. Hence, any contribu-
tion of the intervention in terms of reducing the se-
verity and recurrence of diarrhea has not been
considered. Further, the estimated cost cannot be in-
ferred to other settings as some of its components
(like transportation cost) were peculiar to the study
districts.
Table 4 Comparison of CE ratios in central and HC level bundling approaches






Increased adherence (%) CE ratio
Status quo 0.5562 71.6 – a – a – a
HC level bundling 0.6057 86.5 0.0495 14.9 0.0033
Central bundling 0.6585 86.4 0.1023 14.8 0.0069
a Set as the base value
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Conclusion
Bundling zinc with ORS via a pouch with instructional
messages increases adherence to diarrhea treatment. ‘HC
level bundling’ is more cost effective than the ‘central
bundling’ strategy. Bundling is a feasible approach for
enhancing adherence to diarrhea treatment.
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